They've all participated in the placements quite a bit, and the founder is the second largest holder as well. The CEO has also been buying a bit on market. Obviously it is always nice to see them buying more, but you can't tell someone how to invest all their money, especially when it comes to investing in what is already their primary source of income.
BTW WBT seems mostly to been the issue of "free shares", and a fairly large sale. EYE directors don't do that, when they buy they buy properly (either on market or as part of a placement)
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-412
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $9.907K | 50.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65104 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 51773 | 2 |
View Market Depth
| Last trade - 13.43pm 13/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |